Literature DB >> 24220327

Application of a new technique, spiral tissue microarrays constructed using needle biopsy specimens, to prostate cancer research.

Akira Komiya1, Tomonori Kato, Takashi Hori, Junya Fukuoka, Kenji Yasuda, Hideki Fuse.   

Abstract

Tissue microarrays were constructed using prostate needle biopsy specimens obtained from 58 patients who underwent radical prostatectomy for localized or locally advanced prostate cancer (PC). We used the spiral array (SA) technique, a novel approach for tissue array construction in a spiral form, which has advantages over small needle biopsy specimens. Roll-shaped tissue pieces produced by slicing a prostate biopsy tissue block and trimming the cancer segment were used to obtain a tissue array block. Cancer segments measuring >3 mm were incorporated into the tissue arrays. Cancer fragments (n=253) were obtained from formalin-fixed, paraffin-embedded needle biopsy specimens. The median number of cancer fragments per patient was four (1-8, min-max). On SA, the median number of confirmed cancer fragments per patient was four (1-7) and 224 cancer fragments (88.5%) were confirmed histologically. Each core of reeled tissue contained at least one cancer fragment. The expressions of multiple prognostic molecular markers for PC (Ki-67, p53 and bcl-2) were immunohistochemically measured using the SA. The Ki-67 and bcl-2 expressions were significantly associated with the Gleason score (GS). A univariate analysis identified Ki-67, bcl-2 and GS as significant predictors of cancer-specific survival, p53 and bcl-2 as significant predictors of overall survival and Ki-67, adjuvant androgen deprivation and GS as significant predictors of biochemical progression. In a multivariate analysis, p53 was independently associated with overall survival, while adjuvant androgen deprivation and GS were associated with biochemical progression. These results indicate that SA has potential as a new tool for translational research on PC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24220327     DOI: 10.3892/ijo.2013.2173

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  3 in total

1.  Ki-67 is a strong prognostic marker of non-small cell lung cancer when tissue heterogeneity is considered.

Authors:  Kazuhiro Tabata; Tomonori Tanaka; Tomayoshi Hayashi; Takashi Hori; Sayuri Nunomura; Suguru Yonezawa; Junya Fukuoka
Journal:  BMC Clin Pathol       Date:  2014-05-13

2.  Intratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer.

Authors:  Sayuri Nakamura; Kentaro Hayashi; Yuki Imaoka; Yuka Kitamura; Yuko Akazawa; Kazuhiro Tabata; Ruben Groen; Tomoshi Tsuchiya; Naoya Yamasaki; Takeshi Nagayasu; Junya Fukuoka
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

3.  A next-generation tissue microarray (ngTMA) protocol for biomarker studies.

Authors:  Inti Zlobec; Guido Suter; Aurel Perren; Alessandro Lugli
Journal:  J Vis Exp       Date:  2014-09-23       Impact factor: 1.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.